Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Sep 25, 2007 9:54am
147 Views
Post# 13462156

"Dr. Cruz Quips..........From N Y C ! ! "

"Dr. Cruz Quips..........From N Y C ! ! " Dr. Cruz also had a lot to say about Alzheimers........and the BlockBuster Drug AZD-103/ELND005 Dr. Cruz......"We've completed about 98% of the Tox studys and it's been completely clean. We're just finishing up one last pre-clinical TOX study here, we've had to go to the Maximal Feasible Doses because we didn't have ANY targeted organ Toxicity. In other words this drug is Safe, we didn't see anything iN our Tox Studys so we HAD TO go to MaximAl Feasible Doses." Although I didn't pick up the feed for the slide show........Dr. Cruz did have one for the audience. Dr. Cruz......" We have completed 6 different Phasel Studys with close to 150 people included in these studys. We've had no surprises. Theres been No Adverse Events associated with this drug; we've had no surprises at all. We are NOW in the final stages of finalizing a Phasell Study and we expect to have that FINALIZED BY THE MIDDLE OF OCTOBER." Moving along pretty good considering where we were this time last year.......we hadn't even signed the us$200 MILLION Collaberation Agreement with the worlds most respected Alzheimers R&D Company...........Elan.
Bullboard Posts